Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer

ClinicalTrials.gov ID: NCT01958021

Public ClinicalTrials.gov record NCT01958021. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 12:31 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Double-blind, Placebo-controlled Study of LEE011 in Combination With Letrozole for the Treatment of Postmenopausal Women With Hormone Receptor Positive, HER2 Negative, Advanced Breast Cancer Who Received no Prior Therapy for Advanced Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary purpose of this study was to assess the efficacy of ribociclib, as measured by progression free survival (PFS), in postmenopausal women with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer who received no prior treatment for advanced disease.

Study identification

NCT ID
NCT01958021
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
668 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 100 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 17, 2013 (Actual)
Primary completion
Jan 29, 2016 (Actual)
Completion
Mar 16, 2023 (Actual)
Last update posted
Mar 7, 2025

2013 – 2023

United States locations

U.S. sites
73
U.S. states
28
U.S. cities
65
Facility City State ZIP Site status
Ironwood Cancer and Research Centers Chandler Arizona 85224 —
Arizona Oncology Associates PC HAL Sedona Arizona 86336 —
Highlands Oncology Group Fayetteville Arkansas 72703 —
NEA Baptist Cancer Center Jonesboro Arkansas 72401 —
Alta Bates Cancer Center Berkeley California 94704 —
City of Hope National Medical Center Duarte California 91010 3000 —
Glendale Adventist Medical Center Glendale California 91206 —
The Angeles Clinic and Research Institute Los Angeles California 90025 —
Cedars Sinai Medical Center SC-5 Los Angeles California 90048 —
Comprehensive Cancer Center Sacramento California 95817 —
Univ of Colorado School of Medicine Aurora Colorado 80045 —
Rocky Mountain Cancer Centers Longmont Colorado 80501 —
University Cancer Institute Boynton Beach Florida 33426 —
Florida Cancer Research Institute Davie Florida 33328 —
Florida Cancer Specialists Fort Myers Florida 33901 —
Memorial Hospital Hollywood Florida 33021 —
University Of Miami Miami Florida 33136 —
Florida Retina Institute Orlando Florida 32804 —
Sacred Heart Medical Oncology Pensacola Florida 32504 —
Florida Cancer Specialists-North St. Petersburg Florida 33705 —
Georgia Cancer Specialists Decatur Georgia 30033 —
Lewis Hall Singletary Onc Ctr at John D. Archbold Mem Hosp. Thomasville Georgia 31792 —
Moanalua Medical Center Attn Oncology Dept Honolulu Hawaii 96817 —
University of Illinois Cancer Center at Chicago Chicago Illinois 60612 —
University of Chicago Chicago Illinois 60637 —
NorthShore University Health System Evanston Illinois 60201 —
Ingalls Memorial Hospital Harvey Illinois 60426 —
Edward Hospital Naperville Illinois 60540 —
IU Simon Cancer Center Indianapolis Indiana 46202 —
Sidney Kimmel CCC At JH Baltimore Maryland 21231 —
Frederick Memorial Hospital Frederick Maryland 21701 —
Dana Farber Cancer Institute Boston Massachusetts 02215 —
Allina Hlth Cancer Inst Minneapolis Minneapolis Minnesota 55407 —
Jackson Oncology Associates Jackson Mississippi 39202 —
St Lukes Hos Marion Bloch Neur Inst Kansas City Missouri 64111 —
Mercy Medical Research Institute Manchester Missouri 63021 —
Foundation Medical Partners Nashua New Hampshire 03060 —
Cooper Cancer Center Camden New Jersey 08103 —
Hackensack Meridian Health Edison New Jersey 88837 —
Cancer Institute of New Jersey New Brunswick New Jersey 08901 —
C R Wood Cancer Center at Glens Falls Hospital Glens Falls New York 12801 —
Winthrop University Hospital Mineola New York 11501 —
NYU Langone Med Center CV Research New York New York 10016 —
Mount Sinai School Of Medicine New York New York 10029 —
Montefiore Medical Center The Bronx New York 10467 —
Duke Univ Medical Center Durham North Carolina 27710 —
Oncology Hematology Care Inc Cincinnati Ohio 45242 —
The Ohio State University Comprehensive Cancer Center Columbus Ohio 43221 —
Mercy Clinic Oklahoma Communities Mercy Oncology Oklahoma City Oklahoma 73120 —
Lehigh Valley Hospital Allentown Pennsylvania 18103 —
Penn State Hershey Cancer Institute Hershey Pennsylvania 17033 —
Avera Cancer Sioux Falls South Dakota 57105 —
Chattanooga Onc And Hem Assoc PC Chattanooga Tennessee 37404 —
Sarah Cannon Research Institute Nashville Tennessee 37203 —
Vanderbilt University Medical Ctr Nashville Tennessee 37232 —
Texas Oncology P A Bedford Texas 76022 —
Texas Oncology Dallas Texas 75251 —
University of Texas Southwestern Medical Center Dallas Texas 75390 —
Ctr For Cancer And Blood Disorders Fort Worth Texas 76104 —
Texas Oncology P A Fort Worth Texas 76104 —
Texas Oncology Houston Memorial City Houston Texas 77024 —
Uni Of TX MD Anderson Cancer Cntr Houston Texas 77030 —
Millennium Research Clin Develop Houston Texas 77090 —
Texas Oncology McAllen Texas 78503 —
Richardson Hematology Oncology Associates Richardson Texas 75082 —
Texas Oncology P A San Antonio Texas 78217 —
Texas Oncology Northeast Texas Tyler Texas 75702 —
Utah Cancer Specialists Salt Lake City Utah 84106 —
Virginia Cancer Specialists Fairfax Virginia 22031 —
Oncology and Hematology Associates of Southwest Virginia Inc Salem Virginia 24153 —
Providence Regional Cancer Partnership Everett Washington 98201 —
Northwest Medical Specialties Tacoma Washington 98405 —
Dean Health System Madison Wisconsin 53717 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 148 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01958021, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 7, 2025 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01958021 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →